Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNJ | NVO | LLY | ABBV | MRK |
| Company | Johnson & Johnson | Novo Nordisk A/S ADR | Eli Lilly and Company | Abbvie Inc | Merck & Company |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 149.89 | 122.92 | 743.00 | 161.16 | 128.01 |
| High | 149.89 | 123.77 | 745.00 | 164.25 | 128.48 |
| Low | 147.82 | 121.29 | 730.34 | 160.74 | 127.18 |
| Last | 149.27 | 123.05 | 734.97 | 163.79 | 127.51 |
| Change | -0.65 | -0.97 | -20.94 | +2.98 | -0.75 |
| % Change | -0.43% | -0.78% | -2.77% | +1.85% | -0.58% |
| Volume | 6,532,700 | 5,932,900 | 4,595,100 | 5,850,100 | 6,221,900 |
| 20-Day Average Volume | 8,660,220 | 3,952,025 | 2,753,080 | 5,398,780 | 6,958,650 |
| Previous Close | 149.92 | 124.02 | 755.91 | 160.81 | 128.26 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 148.14 | 125.43 | 749.09 | 165.05 | 127.31 |
| 20-Day Raw Stochastic | 61.99% | 19.18% | 21.59% | 42.88% | 36.27% |
| 20-Day Relative Strength | 45.80% | 45.94% | 46.54% | 43.17% | 52.35% |
| Weighted Alpha | -9.35 | +50.80 | +66.93 | +11.16 | +13.97 |
| Today's Opinion | 88% Sell | 40% Buy | 48% Buy | 8% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 40% Buy | 64% Buy | 8% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 80% Buy | 100% Buy | 64% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.14% since 04/26/24 | -3.00% since 04/26/24 | +0.20% since 04/26/24 | +2.61% since 04/26/24 | -2.81% since 04/26/24 |
| Low | 144.53 on 04/30/24 | 121.29 on 05/03/24 | 729.61 on 04/29/24 | 158.12 on 05/02/24 | 127.18 on 05/03/24 |
| High | 152.33 on 05/02/24 | 130.46 on 04/30/24 | 795.50 on 04/30/24 | 164.25 on 05/03/24 | 132.20 on 04/29/24 |
| 1-Month | |||||
| %Chg | -3.23% since 04/03/24 | -3.10% since 04/03/24 | -5.29% since 04/03/24 | -7.64% since 04/03/24 | -1.84% since 04/03/24 |
| Low | 143.13 on 04/18/24 | 121.29 on 05/03/24 | 718.30 on 04/25/24 | 157.65 on 04/26/24 | 124.50 on 04/18/24 |
| High | 155.50 on 04/04/24 | 130.46 on 04/30/24 | 795.50 on 04/30/24 | 177.70 on 04/04/24 | 132.80 on 04/25/24 |
| 3-Month | |||||
| %Chg | -4.69% since 02/02/24 | +8.22% since 02/02/24 | +10.08% since 02/02/24 | -2.89% since 02/02/24 | +0.87% since 02/02/24 |
| Low | 143.13 on 04/18/24 | 116.27 on 02/05/24 | 682.53 on 02/05/24 | 157.65 on 04/26/24 | 119.23 on 03/15/24 |
| High | 163.11 on 03/12/24 | 138.28 on 03/07/24 | 800.78 on 03/04/24 | 182.89 on 03/12/24 | 133.10 on 03/27/24 |
| 6-Month | |||||
| %Chg | -1.37% since 11/03/23 | +25.34% since 11/03/23 | +29.44% since 11/03/23 | +15.82% since 11/03/23 | +23.34% since 11/03/23 |
| Low | 143.13 on 04/18/24 | 94.73 on 12/11/23 | 561.65 on 12/15/23 | 135.85 on 11/09/23 | 99.80 on 11/29/23 |
| High | 163.58 on 01/22/24 | 138.28 on 03/07/24 | 800.78 on 03/04/24 | 182.89 on 03/12/24 | 133.10 on 03/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 359,244,960 | 552,190,848 | 698,519,104 | 290,014,272 | 322,986,432 |
| Shares Outstanding, K | 2,406,679 | 4,487,532 | 950,405 | 1,770,647 | 2,533,028 |
| Annual Sales | 85,159,000,000 | 33,724,300,000 | 34,124,100,000 | 54,318,000,000 | 60,115,000,000 |
| Annual Net Income | 35,153,000,000 | 12,150,770,000 | 5,240,400,000 | 4,863,000,000 | 365,000,000 |
| Last Quarter Sales | 21,383,000,000 | 9,526,160,000 | 9,353,400,000 | 12,310,000,000 | 15,775,000,000 |
| Last Quarter Net Income | 5,354,000,000 | 3,175,360,000 | 2,189,700,000 | 1,369,000,000 | 4,762,000,000 |
| 60-Month Beta | 0.55 | 0.43 | 0.37 | 0.61 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.71 on 04/16/24 | 0.71 on 01/31/24 | 2.58 on 04/30/24 | 2.31 on 04/26/24 | 2.07 on 04/25/24 |
| Latest Earnings Date | 04/16/24 | 05/02/24 | 04/30/24 | 04/26/24 | 04/25/24 |
| Most Recent Dividend | 1.190 on 02/16/24 | 0.663 on 03/22/24 | 1.300 on 02/14/24 | 1.550 on 04/12/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | 05/20/24 | 03/22/24 | 02/14/24 | 04/12/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 14.33 | 42.77 | 103.83 | 14.67 | 59.11 |